Education
B.S.: University of North Carolina at Chapel Hill; Chapel Hill, North Carolina, USA, 2020 (Molecular Biology)
Graduate Certificate: Stanford University; Stanford, CA, USA, 2023 (Pharmacogenomics)
Positions and Work Experience
2021 -2021 Research Technician , University of Kentucky, Lexington, KY, USA
2022 -2022 Clinical Research Coordinator , Memorial Sloan Kettering Cancer Center, New York, New York, USA
2022 -2022 Clinical Research Associate , University of California at San Diego Moores Cancer Center, San Diego, CA, USA
2022 -2023 Associate Microbiologist , Pfizer-Meridian , St. Louis, MO, USA
2023 - Graduate Assistant and PhD Student, University of Cincinnati, Cincinnati, OH, USA
Publications
Peer Reviewed Publications
Madaan, Tushar; Doan, Kyla; Hartman, Alexandra; Gherardini, Dominick; Ventrola, Alec; Zhang, Yuhang; Kotagiri, Nalinkanth (2024. ) Advances in Microbiome-Based Therapeutics for Dermatological Disorders: Current Insights and Future Directions .Experimental Dermatology, , 33 (12 ) ,e70019
Other Publications
Wen, Patrick; Kaley, Thomas (2022. ) Surgical Nivolumab and Ipilimumab for Recurrent Glioblastoma, NCT04606316 , https://clinicaltrials.gov/study/NCT04606316
McKay, Rana (2021. ) Basket Study of Tucatinib and Trastuzumab in Solid Tumors with HER2 Alterations, NCT04579380 , https://clinicaltrials.ucsd.edu/trial/NCT04579380
Mellinghoff, Ingo (2022. ) Pembrolizumab (MK-3475) in Patients with Recurrent Malignant Glioma with a Hypermutator Phenotype, NCT02658279 , https://www.clinicaltrials.gov/study/NCT02658279